ENABLE-2

Supporting the early stages of discovery and development of new antibiotics

Welcome to ENABLE-2

ENABLE-2 is an antibacterial drug discovery platform with focus on the early stages of antibiotic discovery and development. Supporting the development of direct acting systemic antibacterial compounds, we ensure that there is a complete global development pipeline for new antibiotics.

ENABLE-2 is based on learnings from ENABLE (Innovative Medicines Initiative) and supported by the Swedish Research Council and the National Research Programme on Antibiotic Resistance.

Our platform, gathering together an international team of experienced scientists, is open to Swedish academia and, through support from Vinnova, to SMEs. In March 2022 we launched with four promising projects in the pursuit of new antibiotics.

ENABLE-2 Logos
Last modified: 2022-12-05